Our discovery of the pivotal role of Rac1 in enhancing nucleotide metabolism and inducing chemoresistance in multiple human cancers makes Rac1 as an attractive therapeutic target for potent sensitization to DNA damaging chemotherapies. This evidence concerns the gene RAC1 and cancer.